ConductScience.org, home

Paper20831742

A systematic review of duloxetine and venlafaxine in major depression, including unpublished data.

Schueler YB and 9 others. Acta Psychiatr Scand, 2011. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. A systematic review of duloxetine and venlafaxine in major depression, including unpublished data. Papers, record 20831742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20831742

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A systematic review of duloxetine and venlafaxine in major depression, including unpublished data.
PubMed
Journal
Acta Psychiatr Scand
PubMed
Year
2011
PubMed
Publication types
Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
1.68
iCite
Revised in PubMed
2026-01-28
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schueler YBY-B
2Koesters MM
3Wieseler BB
4Grouven UU
5Kromp MM
6Kerekes MFM F
7Kreis JJ
8Kaiser TT
9Becker TT
10Weinmann SS

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive Agents, TricyclicMajor topic
CyclohexanolsMajor topic
Major Depressive DisorderMajor topic
ThiophenesMajor topic
Adult
Antidepressive Agents, Second-Generation
Dose-Response Relationship, Drug
Drug Resistance
Duloxetine Hydrochloride
Humans
Pharmacological Phenomena
Randomized Controlled Trials as Topic
Remission Induction
Therapeutic Equivalency
Treatment Outcome
Venlafaxine Hydrochloride

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
42765056Venlafaxine for the Prevention of Postherpetic Neuralgia in Patients with Acute Herpes Zoster: Protocol for a Randomized Controlled Trial.J Pain Res2026https://conductscience.org/library/papers/42765056PubMed
41646204Examining individual serotonin and norepinephrine reuptake inhibitors and fall-related hospitalizations in older adults.Ment Health Clin2026https://conductscience.org/library/papers/41646204PubMed
39440379The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.Epidemiol Psychiatr Sci2024https://conductscience.org/library/papers/39440379PubMed
37644009Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37644009PubMed
36831876Current Opinions about the Use of Duloxetine: Results from a Survey Aimed at Psychiatrists.Brain Sci2023https://conductscience.org/library/papers/36831876PubMed
35947166Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine.Psychopharmacology (Berl)2022https://conductscience.org/library/papers/35947166PubMed
35815048Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults.Front Psychiatry2022https://conductscience.org/library/papers/35815048PubMed
34108032
Duloxetine versus 'active' placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
Syst Rev2021https://conductscience.org/library/papers/34108032PubMed
31920318MicroRNA-Based Biomarkers in the Diagnosis and Monitoring of Therapeutic Response in Patients with Depression.Neuropsychiatr Dis Treat2019https://conductscience.org/library/papers/31920318PubMed
30122927Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review.Neuropsychiatr Dis Treat2018https://conductscience.org/library/papers/30122927PubMed
29024974Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient.Int J Neuropsychopharmacol2018https://conductscience.org/library/papers/29024974PubMed
28677828Vortioxetine for depression in adults.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28677828PubMed
26628045[Tricyclic antidepressants for initial treatment of depressive episodes? Pro].Nervenarzt2016https://conductscience.org/library/papers/26628045PubMed
25037293A systematic approach to pharmacotherapy for geriatric major depression.Clin Geriatr Med2014https://conductscience.org/library/papers/25037293PubMed
24101861Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.Drug Des Devel Ther2013https://conductscience.org/library/papers/24101861PubMed
23281074Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.Birth Defects Res A Clin Mol Teratol2013https://conductscience.org/library/papers/23281074PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20831742

GET https://conductscience.org/api/papers/v1/20831742/authors